BIIB Quote, Trading Chart, Biogen Inc.
home / stock / biib / biib quote
$271.12 Last:
0.44% Change Percent:
$269.88 Open:
$271.12 Previous Close:
$273.64 High:
$267.02 Low:
1,449,362 Volume:
10/26/2021 04:56:09 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
BIIB Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-10-26 | 269.88 | 271.12 | 273.64 | 267.02 | 1,449,362 |
| 2021-10-25 | 266 | 269.94 | 271.51 | 265 | 1,091,624 |
| 2021-10-22 | 269.38 | 264.8 | 270.37 | 264.3518 | 870,017 |
| 2021-10-21 | 266.3 | 270.21 | 271.94 | 266.29 | 1,370,892 |
| 2021-10-20 | 270.11 | 266.57 | 277.87 | 264.78 | 2,138,164 |
| 2021-10-19 | 270 | 268.13 | 271.66 | 266.3 | 1,790,241 |
| 2021-10-18 | 279.42 | 269.73 | 279.5 | 269.19 | 1,475,830 |
| 2021-10-15 | 285.34 | 281.19 | 286 | 278.57 | 1,294,855 |
| 2021-10-14 | 286.0008 | 285.26 | 287.93 | 282.65 | 703,519 |
| 2021-10-13 | 284.9 | 283.65 | 285.3 | 280.5 | 517,985 |
| 2021-10-12 | 285.48 | 284.79 | 288.59 | 283.7901 | 616,116 |
| 2021-10-11 | 284.65 | 285.59 | 288.77 | 283.45 | 620,547 |
| 2021-10-08 | 287.44 | 285.83 | 288.99 | 284 | 629,534 |
| 2021-10-07 | 285.52 | 287.77 | 290.76 | 284.585 | 850,441 |
| 2021-10-06 | 280.12 | 283.55 | 285.57 | 279.12 | 967,311 |
| 2021-10-05 | 278.34 | 280.44 | 282.26 | 278.34 | 1,001,445 |
| 2021-10-04 | 281.44 | 278.32 | 284.5599 | 277.41 | 924,891 |
| 2021-10-01 | 281.35 | 283.94 | 285.41 | 279.24 | 922,021 |
| 2021-09-30 | 286.23 | 282.99 | 287.8 | 282.64 | 777,389 |
| 2021-09-29 | 285.76 | 285.56 | 289.335 | 284.635 | 697,548 |
News, Short Squeeze, Breakout and More Instantly...
-
--News Direct-- ATLANTA, October 26, 2021 /3BL Media/ - Morehouse School of Medicine MD and PhD students, starting in June 2022, will be offered a remarkable learning opportunity in collaboration with Biogen that contributes to both organizations’ missions to advance health equit...
-
The economy is in recovery mode with the rapid roll-out of vaccines. A solid start to the third-quarter earnings season, a decline in the initial jobless claims, and declining COVID-19 cases are helping the major stock indexes perform well. Therefore, we think quality stocks Bristol-Myers (BM...
-
Biogen (NASDAQ: BIIB) announced its third-quarter results on Wednesday. Most of the headlines covering this update focused on the company's better-than-expected revenue and earnings. It's certainly true that Biogen did top analysts' estimates on both the top and bottom lines. Ho...